Jeff Goater
SVP Finance, Bus. Development, Voyager Therapeutics (United States).
Companies
- Surface Oncology, Inc.Board member Apr 18, 2018 to Sep 8, 20231
- LogicBio Therapeutics, Inc.Board member Dec 14, 2020 to Nov 17, 20222
- VACCINEX, INC.Board member Aug 9, 2018 to May 12, 20213
- Surface Oncology, Inc.Chief executive officer Apr 18, 2018 to Feb 9, 20211
- Voyager Therapeutics (United States)Chief financial officer Feb 2, 2016 to Feb 2, 20164
- Voyager Therapeutics (United States)SVP Finance, Bus. Development Nov 10, 2015 to Nov 10, 20155
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Surface Oncology, Inc.0 shares6Sep 8, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 8, 2023Returned to company 129,222 shares of Surface Oncology, Inc.6
- Jul 21, 2021Sold 127,778 shares at $6.10 of Surface Oncology, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSurface Oncology, Inc., Board member
- 2
- 3SEC EDGARVACCINEX, INC., Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jan 14, 2022